3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD

Similar documents
MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

Imaging to select patients for Transcatheter TV

Management of TR in Patients Undergoing Mitral Interventions

Tricuspid and Pulmonary Valve Disease

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Management of Tricuspid Regurgitation

When Does 3D Echo Make A Difference?

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Assessing the Impact on the Right Ventricle

Tricuspid and Pulmonary Valve Disease

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA

Mitral Valve Disease, When to Intervene

Disclosures Rebecca T. Hahn, MD, FASE

ΓΙΩΡΓΟΣ ΜΑΚΑΒΟΣ, MD, PhD ΚΑΡΔΙΟΛΟΓΟΣ, ΕΠΙΜΕΛΗΤΗΣ Β Γ ΠΑΝΕΠΙΣΤΗΜΙΑΚΗ ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ Γ.Ν.Ν.Θ.Α. ΣΩΤΗΡΙΑ

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Atrioventricular valve repair: The limits of operability

Isolated tricuspid valve surgery: timing and indications

Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency

Assessment of Tricuspid and Pulmonic Valve Disease: Importance of 3D

Trans-catheter TV repair Leaflet or Annuloplasty Techniques

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Ανεπάρκεια Τριγλώχινας Επιλογή Επεμβατικής Θεραπείας. Μ. Χρυσοχέρης Τμήμα Διαδερμικών Βαλβίδων ΔΘΚΑ ΥΓΕΙΑ

Risk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

What are the best diagnostic tools to quantify aortic regurgitation?

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

How to assess ischaemic MR?

Edwards' solution for patients suffering from tricuspid valve disease

Tricuspid leaflet repair: innovative solutions

Ischemic Mitral Regurgitation

Concomitant Tricuspid Valve Repair :

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

The difficult patient with mitral regurgitation

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

ECHO HAWAII. My home. Pulmonary Hypertension and Pulmonary Embolism: Role of Echo U.S.A. Japan. Hawaii Island 1/9/2018

가천의대길병원소아심장과최덕영 PA C IVS THE EVALUATION AND PRINCIPLES OF TREATMENT STRATEGY

Functional Mitral Regurgitation

Echocardiographie de la Tétralogie de Fallot opérée

PISA Evaluation of Mitral Regurgitation. Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011

RIGHT VENTRICULAR SIZE AND FUNCTION

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Aortic stenosis with concomitant mitral regurgitation

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

Right Heart Hemodynamics: Echo-Cath Discrepancies

Professors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo

Usefulness of 3D echocardiographic parameters of tricuspid valve morphology to predict residual tricuspid regurgitation after tricuspid annuloplasty

MITRAL STENOSIS. Joanne Cusack

Ο ΡΟΛΟΣ ΤΩΝ ΚΟΛΠΩΝ ΣΤΗ ΛΕΙΤΟΥΡΓΙΚΗ ΑΝΕΠΑΡΚΕΙΑ ΤΩΝ ΚΟΛΠΟΚΟΙΛΙΑΚΩΝ ΒΑΛΒΙΔΩΝ

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

EVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

Cover Page. The handle holds various files of this Leiden University dissertation.

25 different brand names >44 different models Sizes mm

Next Generation Therapies: Aortic, Mitral and Beyond

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Tayyar Gökdeniz, Emre Ertürk, M. Ali Astarcıoğlu, Sabahattin Gündüz, A. Çağrı Aykan, A. Emrah Oğuz, Zübeyde Bayram, Mustafa Yıldız, N.

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Objectives. Considerations in management of multivalvular disease. Case Discussions. A Systematic Approach to Multivalve Disease.

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies

April 16, 09:00-09:15 중앙대학교 윤신원

Cover Page. The handle holds various files of this Leiden University dissertation.

Quantitation of Aortic Regurgitation ASCeXAM / ReASCE Review Course

Mohammad Sharif Popal, Jin-Tao Fu, Qiu-Ming Hu, Tian-Ge Luo, Shuai Zheng, Xu Meng

Giovanni Di Salvo MD, PhD, FESC Second University of Naples Monaldi Hospital

Organic mitral regurgitation

Quantitative Assessment of Pulmonary Regurgitation by Echocardiography in Patients After Repaired TOF

Commentary:Right Ventricular-Tricuspid Valve Interdependance And The Challenges For Structural Heart Valve Therapy

What echo measurements are key prior to MitraClip?

When should we intervene surgically in pediatric patient with MR?

Imaging Assessment of the Pulmonary Valve in Stenosis/Atresia and Regurgitation

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology

LUST trial. Echocardiography USER S MANUAL

Haiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction

Quantifying Aortic Regurgitation

MITRAL REGURGITATION ECHO PARAMETERS TOOL

Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας

The tricuspid valve has long been described as

Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!

Pulmonary Regurgitation after TOF Repair. How to Assess and Options of Management? Worakan Promphan, MD.FSCAI.

Chamber Quantitation Guidelines: What is New?

Recognition of the significant morbidity and mortality

COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE?

Cases in Adult Congenital Heart Disease

Swan Song: Echocardiography as a Pulmonary Artery Catheter? Interdepartmental Division of Critical Care Medicine

Imaging of Repaired Tetralogy of Fallot in Adults

Echocardiography: Guidelines for Valve Quantification

Pulmonary Hypertension. Echocardiography: Pearls & Pitfalls

Titel Kardiologie-SG.ch hot topics in heart failure and mitral regurgitation

Aortic Regurgitation & Aorta Evaluation

Transcription:

3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD Asan Medical Center University of Ulsan College of Medicine Seoul, Korea

Causes of TR Primary causes (25%) Rheumatic Myxomatous Ebstein anomaly Endomyocardial fibrosis Endocarditis Carcinoid disease Traumatic (blunt chest injury, laceration) Iatrogenic (pacemaker/defibrillator lead, RV biopsy) Secondary causes (75%) Left heart disease (LV dysfunction or valve disease) resulting in pulmonary hypertension Any cause of pulmonary hypertension (chronic lung disease, pulmonary thromboembolism, left to right shunt) Any cause of RV dysfunction (myocardial disease, RV ischemia/infarction) Circulation. 2009;119:2718-2725

Functional TR Often accompanies various left-side valvular heart and myocardial diseases. Associated with worse survival Nath J, J Am Coll Cardiol 2004;43;405-9.

Pathogenesis of FTR Geometric Alteration of TV Annulus dilation Dreyfus GD. Ann Thorac Surg. 2005;79:127-132. Colombo T. Cardiovasc Surg. 2001;9:369-77. Mikami T. Am J Cardiol 1984;53:160-3. Ubago JL. Am J Cardiol. 1983;52:155-8. Leaflet tethering/tenting Fukuda S. Circulation. 2005;111:975-979. Sugimoto T. J Thorac Cardiovasc Surg. 1999;117:463-71. Sagie A. Doppler color flow study. J Am Coll Cardiol. 1994;24:446-53.

Annulus Dilation Dreyfus GD, Ann Thorac Surg. 2005;79:127-132

Tricuspid Annulus Fukuda S, Circulation. 2006;114(suppl):I-492 I-498

Geometric Determinants of FTR Ton-Nu T et al. Circulation. 2006;114:143-9

Geometric Determinants of FTR Ton-Nu T et al. Circulation. 2006;114:143-9

Geometric Determinants of FTR Ton-Nu T et al. Circulation. 2006;114:143-9

Geometric Determinants of FTR Ton-Nu T et al. Circulation. 2006;114:143-9

Dynamic Change of Annulus Miglioranza MH, JASE 2015;28:226-35

Tricuspid Leaflets on 2D Echo Feigenbaum s Echocardiography

Tricuspid Leaflets on 2D Echo Badano LP, Eur J Echocardiogr 2009;10:477 84

Tricuspid Valve

3D Echo for Tricuspid Valve

Tricuspid Leaflets on 2D Echo Addetia K et al, JASE 2016;29:74-82

Tricuspid Leaflets on 2D Echo Hahn RT, Circ Cardiovasc Imaging.2016;9:e005332

Tricuspid Leaflets on 2D Echo Addetia K et al, JASE 2016;29:74-82

Tricuspid Leaflets on 2D Echo Hahn RT, Circ Cardiovasc Imaging.2016;9:e005332

Tricuspid Leaflets on 2D Echo Addetia K et al, JASE 2016;29:74-82

Tricuspid Leaflets on 2D Echo Hahn RT, Circ Cardiovasc Imaging.2016;9:e005332

3D Echo for TV

Geometric Determinants of FTR 54 patients with various degrees of functional tricuspid regurgitation P A S P A S P A S A P S A S P S-L plane A-P plane Park YH et al. IJC 2008;124:160-5

Leaflet Tethering/Tenting Fukuda S, Circulation. 2005;111:975-979

Angle ( ) Geometric Determinants of FTR 2D color A P S 40 Sα Pα Mild 30 Aα * 20 * Moderate * 10 Severe 0 Mild Moderate Severe (N=11) (N=32) (N=11) * p<0.05, p<0.005 vs. Aα Park YH et al. IJC 2008;124:160-5

Distal Jet Area / RA Area Geometric Determinants of FTR Variables r Univariate P Multivariate P Aα 0.48 < 0.001 0.31 Pα 0.31 < 0.05 0.58 Sα 0.46 < 0.001 < 0.005 Septal-lateral (S-L) annulus diameter 0.47 < 0.001 < 0.01 Antero-posterior annulus diameter 0.46 < 0.001 0.58 Tricuspid tenting volume 0.49 < 0.001 0.30 Pulmonary artery systolic pressure (PASP) 0.36 < 0.01 < 0.05 1.00 0.75 Y=0.009X+0.20 R=0.46 P<0.001 N=54 1.00 0.75 Y=0.18X-0.28 R=0.47 P<0.001 N=54 1.00 0.75 Y=0.006X+0.11 R=0.36 P<0.01 N=54 0.50 0.50 0.50 0.25 0.25 0.25 0.00 0 20 40 60 0.00 0 0.00 2 3 4 5 0 20 40 60 80 Sα ( ) S-L diameter (cm) PASP (mm Hg)

Residual TR after TAP Although significant FTR is usually surgically managed using tricuspid annuloplasty (TAP), some studies reported persistence of FTR in nearly 50% of patients following TAP. Matsunaga A, Circulation. 2005;112:I453-457

Predictors of Residual TR after TAP Fukuda S, Circulation. 2005;111:975-979

Geometric Change After TAP A P S S-L A-P Min SY, Eur Heart J. 2010:31; 2871 2880

Predictors of Severe TR After TAP Min SY, Eur Heart J. 2010:31; 2871 2880

Vena Contracta in FTR Sugeng L, JASE 2007;20:1050-1057

Short-axis plane Vena Contracta Widths A Septal-lateral plane Antero-posterior plane B Song JM, JASE 2011;24:663-70

Measurements by RT3DE A B Anterior Posterior Septal Song JM, JASE 2011;24:663-70

Vena Contracta Width (cm) Vena Contracta Area (cm 2 ) EROA & Vena Contracta r=0.761 p<0.001 r=0.808 p<0.001 r=0.782 p<0.001 S-L VC A-P VC EROA (cm 2 ) A-P VC S-L VC: 0.39 0.37 cm, p<0.001 EROA (cm 2 ) Song JM, JASE 2011;24:663-70

Tricuspid Valve Circulation. 2009;119:2718-2725 Circulation. 1971;43:333-48

Quantification of TR JASE 2003;16:777-802

Stage of TR 2014 AHA/ACC Guideline

3D Vena Contracta Moderate TR Severe TR A-P VC: 0.76 cm Sensitivity 100% Specificity 66% VC Area: 0.37 cm 2 Sensitivity 100% Specificity 69% VC Area: 0.57 cm 2 Sensitivity 100% Specificity 64% A-P VC: 1.26 cm Sensitivity 88% Specificity 80% S-L VC: 0.63 cm Sensitivity 82% Specificity 83% S-L VC A-P VC VC Area S-L VC: 0.84 cm Sensitivity 75% Specificity 91% S-L VC A-P VC VC Area Song JM, JASE 2011;24:663-70

Organic TR

Transcatheter Intervention for TR Trialign TM system (Mitralign Inc.) Hahn RT, Circ Cardiovasc Imaging.2016;9:e005332

Transcatheter Intervention for TR Forma Spacer (Edwards Lifesciences) Hahn RT, Circ Cardiovasc Imaging.2016;9:e005332

Summary 3D echo is useful in patients with TR Annulus dilatation Leaflet tethering & tenting Predicting residual TR after TAP Evaluating severity of TR Primary cause of TR Guiding interventional treatment of TR